Stay updated with breaking news from Davidj Hunter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Platelet-rich plasma injections did not significantly improve knee osteoarthritis pain symptoms or joint structure compared with placebo injections in a randomized controlled trial.
Jan Murtha was named executive director of the North Dakota Retirement & Investment Office.
North Dakota discloses 2 commitments of up to $215 million North Dakota discloses 2 commitments of up to $215 million Print North Dakota State Investment Board, Bismarck, approved two commitments totaling up to $215 million, said David J. Hunter, executive director and chief investment officer of the North Dakota Retirement & Investment Office. The board at its May 21 meeting approved a commitment of up to $150 million to ISQ Global Infrastructure Fund III, an infrastructure fund managed by I Squared Capital. Of the $150 million approved for the commitment, $90 million is targeted for the st...
North Dakota State Investment Board, Bismarck, hired 50 South Capital to manage $250 million in an in-state investment program for the $8.2 billion Legacy Trust Fund, said David J. Hunter, executive director and chief investment officer of the North Dakota Retirement & Investment Office.The…
E-Mail Although guidelines do not recommend use of opioids to manage pain for individuals with knee osteoarthritis, a recent study published early online in Arthritis Care & Research, an official journal of the American College of Rheumatology and the Association of Rheumatology Professionals, estimates that 858,000 Americans use opioids such as tramadol and oxycodone for their knee pain, equating to $14 billion in lifetime opioid-related societal costs, or nearly $0.5 billion annually. A team led by Elena Losina, PhD, Robert W. Lovett Professor of Orthopedic Surgery, of Brigham and Wome...